Visiongain publishes 3D Printed Surgical Models Market Report 2020-2030

29 April 2020

Visiongain has launched a new pharma report 3D Printed Surgical Models Market Report 2020-2030: Forecasts by Specialty (Cardiac Surgery/Interventional Cardiology, Gastroenterology Endoscopy of Esophageal, Neurosurgery, Orthopedic Surgery, Reconstructive Surgery, Surgical Oncology, Transplant Surgery), and Geography (North America, Latin America, Europe, Asia Pacific, MEA).

The global 3D printed surgical models market is anticipated to grow at a lucrative CAGR of xyz% and projected to surpass USD 650 Million by 2020. The market is anticipated to grow on account of the rising requirement for prototyping test models from healthcare enterprises and growing R&D investments across the industry. Furthermore, Visiongain anticipates that the rising number of surgical procedures coupled with rising chronic diseases is leading to the need for customized healthcare products which is fueling the global market growth and a similar trend is projected over the forecast period.

To access the data contained in this document please email

3D surgical models are used to enhance the perception of the planned operation in 3D, either as a visual-tactile aid or as a mock operation. It helps to pre-adapt surgical instruments such as fixing plates and therefore shortens the operation and improves precision.

The medical industry is rapidly embracing the cutting-edge manufacturing of anatomical 3D printed models for pre-operative procedural planning. The pre-procedural 3D printed models are low-cost and are tailored to individual patients. The printed models offer physicians the opportunity to map their procedures in a risk-free surgical setting. The quickly produced and delivered models help with validation of the procedure, ultimately improving patient outcomes.

North America holds the majority of market share followed by Europe and will continue to dominate in the future as a result of several research projects in the region, coupled with funding for research institutes from the government. Also, the market will continue to be driven by the existence of the target population and increased R&D investment by important business organizations.

Additionally, growing geriatric population, developed healthcare infrastructure, high purchasing power are anticipated to boost market growth across the North American region. However, the Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to the growing patient pool across the markets such as India and China. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost the 3D Printed Surgical Models Market growth over the forecast period.

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the global market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the 3D Printed Surgical Models Market.

For instance, on 8th April 2020, SLM Solutions announced its partnership with Canwell Medical. Canwell Medical decided to use SLM® machines for product development of 3D printed surgical implants. SLM Solutions will provide technical, application assistance, & R&D support to further accelerate Canwell Medical’s product certification and serial production.

The comprehensive market report features companies such as 3D Systems, Inc., Axial3D, Formlabs, EnvisionTEC, GPI Prototype, Materialise N.V., Lazarus 3D, LLC, Osteo3D, Onkos Surgical, 3D LifePrints UK Ltd., Stratasys Ltd, WhiteClouds Inc. among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020-2030 for global markets such as North America, Latin America, Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, India, Japan, China, Australia, ASEAN, GCC and South Africa.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021


Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021


Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021


Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021